Press Release: Gateway Genomics : Gateway Genomics Surpasses 1500 Clinical Locations Across the US, UK, and Canada
Attracted by a science-based, accurate fetal sex test to acquire new clients and patients early in pregnancy, the number of clinical locations offering SneakPeek Gender DNA Test climbed in 2021.(PRWeb January 12, 2022)Read the full story at https://www.prweb.com/releases/gateway_genomics_surpasses_1500_clinical_locations_across_the_us_uk_and_canada/prweb18430907.htm
Read full article »
Gateway Genomics is a California-based biotechnology firm that develops and commercializes non-invasive prenatal and early gender DNA test kits for parents.
Read more